Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1998 Oct 15;102(8):1481–1488. doi: 10.1172/JCI3011

Inactivation of the gene for anticoagulant protein C causes lethal perinatal consumptive coagulopathy in mice.

L R Jalbert 1, E D Rosen 1, L Moons 1, J C Chan 1, P Carmeliet 1, D Collen 1, F J Castellino 1
PMCID: PMC508997  PMID: 9788960

Abstract

Matings of mice heterozygous for a protein C (PC) deficient allele, produced by targeted PC gene inactivation, yielded the expected Mendelian distribution of PC genotypes. Pups with a total deficiency of PC (PC-/-), obtained at embryonic day (E) 17.5 and at birth, appeared to develop normally macroscopically, but possessed obvious signs of bleeding and thrombosis and did not survive beyond 24 h after delivery. Microscopic examination of tissues and blood vessels of E17.5 PC-/- mice revealed their normal development, but scattered microvascular thrombosis in the brain combined with focal necrosis in the liver was observed. In addition, bleeding was noted in the brain near sites of fibrin deposition. The severity of these pathologies was exaggerated in PC-/- neonates. Plasma clottable fibrinogen was not detectable in coagulation assays in PC-/- neonatal mice, suggestive of fibrinogen depletion and secondary consumptive coagulopathy. Thus, while total PC deficiency did not affect the anatomic development of the embryo, severe perinatal consumptive coagulopathy occurred in the brain and liver of PC-/- mice, suggesting that a total PC deficiency is inconsistent with short-term survival.

Full Text

The Full Text of this article is available as a PDF (8.5 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Awidi A. S., Abu-Khalaf M., Herzallah U., Abu-Rajab A., Shannak M. M., Abu-Obeid T., al-Taher I., Anshasi B. Hereditary thrombophilia among 217 consecutive patients with thromboembolic disease in Jordan. Am J Hematol. 1993 Oct;44(2):95–100. doi: 10.1002/ajh.2830440205. [DOI] [PubMed] [Google Scholar]
  2. Bajzar L., Kalafatis M., Simioni P., Tracy P. B. An antifibrinolytic mechanism describing the prothrombotic effect associated with factor VLeiden. J Biol Chem. 1996 Sep 20;271(38):22949–22952. doi: 10.1074/jbc.271.38.22949. [DOI] [PubMed] [Google Scholar]
  3. Berdeaux D. H., Abshire T. C., Marlar R. A. Dysfunctional protein C deficiency (type II). A report of 11 cases in 3 American families and review of the literature. Am J Clin Pathol. 1993 Jun;99(6):677–686. doi: 10.1093/ajcp/99.6.677. [DOI] [PubMed] [Google Scholar]
  4. Bi L., Lawler A. M., Antonarakis S. E., High K. A., Gearhart J. D., Kazazian H. H., Jr Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A. Nat Genet. 1995 May;10(1):119–121. doi: 10.1038/ng0595-119. [DOI] [PubMed] [Google Scholar]
  5. Connolly A. J., Ishihara H., Kahn M. L., Farese R. V., Jr, Coughlin S. R. Role of the thrombin receptor in development and evidence for a second receptor. Nature. 1996 Jun 6;381(6582):516–519. doi: 10.1038/381516a0. [DOI] [PubMed] [Google Scholar]
  6. Cransac M., Carles J., Bernard P. H., Malavialle P., Freyburger G., Winnock S., Saric J. Heterozygous protein C deficiency and dysfibrinogenemia acquired by liver transplantation. Transpl Int. 1995;8(4):307–311. doi: 10.1007/BF00346885. [DOI] [PubMed] [Google Scholar]
  7. Cui J., O'Shea K. S., Purkayastha A., Saunders T. L., Ginsburg D. Fatal haemorrhage and incomplete block to embryogenesis in mice lacking coagulation factor V. Nature. 1996 Nov 7;384(6604):66–68. doi: 10.1038/384066a0. [DOI] [PubMed] [Google Scholar]
  8. D'Angelo A., Lockhart M. S., D'Angelo S. V., Taylor F. B., Jr Protein S is a cofactor for activated protein C neutralization of an inhibitor of plasminogen activation released from platelets. Blood. 1987 Jan;69(1):231–237. [PubMed] [Google Scholar]
  9. Dahlbäck B. The protein C anticoagulant system: inherited defects as basis for venous thrombosis. Thromb Res. 1995 Jan 1;77(1):1–43. doi: 10.1016/0049-3848(94)00138-4. [DOI] [PubMed] [Google Scholar]
  10. Esmon C. T., Taylor F. B., Jr, Snow T. R. Inflammation and coagulation: linked processes potentially regulated through a common pathway mediated by protein C. Thromb Haemost. 1991 Jul 12;66(1):160–165. [PubMed] [Google Scholar]
  11. Esmon N. L., Owen W. G., Esmon C. T. Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C. J Biol Chem. 1982 Jan 25;257(2):859–864. [PubMed] [Google Scholar]
  12. Foster D. C., Yoshitake S., Davie E. W. The nucleotide sequence of the gene for human protein C. Proc Natl Acad Sci U S A. 1985 Jul;82(14):4673–4677. doi: 10.1073/pnas.82.14.4673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Foster D., Davie E. W. Characterization of a cDNA coding for human protein C. Proc Natl Acad Sci U S A. 1984 Aug;81(15):4766–4770. doi: 10.1073/pnas.81.15.4766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gerson W. T., Dickerman J. D., Bovill E. G., Golden E. Severe acquired protein C deficiency in purpura fulminans associated with disseminated intravascular coagulation: treatment with protein C concentrate. Pediatrics. 1993 Feb;91(2):418–422. [PubMed] [Google Scholar]
  15. Gordon S. G., Mourad A. M. The site of activation of factor X by cancer procoagulant. Blood Coagul Fibrinolysis. 1991 Dec;2(6):735–739. doi: 10.1097/00001721-199112000-00007. [DOI] [PubMed] [Google Scholar]
  16. Grey S. T., Tsuchida A., Hau H., Orthner C. L., Salem H. H., Hancock W. W. Selective inhibitory effects of the anticoagulant activated protein C on the responses of human mononuclear phagocytes to LPS, IFN-gamma, or phorbol ester. J Immunol. 1994 Oct 15;153(8):3664–3672. [PubMed] [Google Scholar]
  17. He X., Shen L., Bjartell A., Malm J., Lilja H., Dahlbäck B. The gene encoding vitamin K-dependent anticoagulant protein C is expressed in human male reproductive tissues. J Histochem Cytochem. 1995 Jun;43(6):563–570. doi: 10.1177/43.6.7769227. [DOI] [PubMed] [Google Scholar]
  18. Healy A. M., Rayburn H. B., Rosenberg R. D., Weiler H. Absence of the blood-clotting regulator thrombomodulin causes embryonic lethality in mice before development of a functional cardiovascular system. Proc Natl Acad Sci U S A. 1995 Jan 31;92(3):850–854. doi: 10.1073/pnas.92.3.850. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Huang Z. F., Higuchi D., Lasky N., Broze G. J., Jr Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice. Blood. 1997 Aug 1;90(3):944–951. [PubMed] [Google Scholar]
  20. Jalbert L. R., Rosen E. D., Lissens A., Carmeliet P., Collen D., Castellino F. J. Nucleotide structure and characterization of the murine gene encoding anticoagulant protein C. Thromb Haemost. 1998 Feb;79(2):310–316. [PubMed] [Google Scholar]
  21. Jamison C. S., McDowell S. A., Marlar R. A., Degen S. J. Developmental expression of protein C and protein S in the rat. Thromb Res. 1995 Jun 1;78(5):407–419. doi: 10.1016/0049-3848(95)00074-2. [DOI] [PubMed] [Google Scholar]
  22. Kisiel W., Canfield W. M., Ericsson L. H., Davie E. W. Anticoagulant properties of bovine plasma protein C following activation by thrombin. Biochemistry. 1977 Dec 27;16(26):5824–5831. doi: 10.1021/bi00645a029. [DOI] [PubMed] [Google Scholar]
  23. Konecki D. S., Brennand J., Fuscoe J. C., Caskey C. T., Chinault A. C. Hypoxanthine-guanine phosphoribosyltransferase genes of mouse and Chinese hamster: construction and sequence analysis of cDNA recombinants. Nucleic Acids Res. 1982 Nov 11;10(21):6763–6775. doi: 10.1093/nar/10.21.6763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Leytus S. P., Foster D. C., Kurachi K., Davie E. W. Gene for human factor X: a blood coagulation factor whose gene organization is essentially identical with that of factor IX and protein C. Biochemistry. 1986 Sep 9;25(18):5098–5102. doi: 10.1021/bi00366a018. [DOI] [PubMed] [Google Scholar]
  25. Lin H. F., Maeda N., Smithies O., Straight D. L., Stafford D. W. A coagulation factor IX-deficient mouse model for human hemophilia B. Blood. 1997 Nov 15;90(10):3962–3966. [PubMed] [Google Scholar]
  26. Marlar R. A., Neumann A. Neonatal purpura fulminans due to homozygous protein C or protein S deficiencies. Semin Thromb Hemost. 1990 Oct;16(4):299–309. doi: 10.1055/s-2007-1002683. [DOI] [PubMed] [Google Scholar]
  27. Mullen C. A., Kilstrup M., Blaese R. M. Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system. Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):33–37. doi: 10.1073/pnas.89.1.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Nachman R. L., Silverstein R. Hypercoagulable states. Ann Intern Med. 1993 Oct 15;119(8):819–827. doi: 10.7326/0003-4819-119-8-199310150-00008. [DOI] [PubMed] [Google Scholar]
  29. Nagy A., Rossant J., Nagy R., Abramow-Newerly W., Roder J. C. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8424–8428. doi: 10.1073/pnas.90.18.8424. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. O'Hara P. J., Grant F. J., Haldeman B. A., Gray C. L., Insley M. Y., Hagen F. S., Murray M. J. Nucleotide sequence of the gene coding for human factor VII, a vitamin K-dependent protein participating in blood coagulation. Proc Natl Acad Sci U S A. 1987 Aug;84(15):5158–5162. doi: 10.1073/pnas.84.15.5158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Orthner C. L., Bhattacharya P., Strickland D. K. Characterization of a protein C activator from the venom of Agkistrodon contortrix contortrix. Biochemistry. 1988 Apr 5;27(7):2558–2564. doi: 10.1021/bi00407a043. [DOI] [PubMed] [Google Scholar]
  32. Rezaie A. R. Rapid activation of protein C by factor Xa and thrombin in the presence of polyanionic compounds. Blood. 1998 Jun 15;91(12):4572–4580. [PubMed] [Google Scholar]
  33. Rosen E. D., Chan J. C., Idusogie E., Clotman F., Vlasuk G., Luther T., Jalbert L. R., Albrecht S., Zhong L., Lissens A. Mice lacking factor VII develop normally but suffer fatal perinatal bleeding. Nature. 1997 Nov 20;390(6657):290–294. doi: 10.1038/36862. [DOI] [PubMed] [Google Scholar]
  34. Shivdasani R. A., Rosenblatt M. F., Zucker-Franklin D., Jackson C. W., Hunt P., Saris C. J., Orkin S. H. Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development. Cell. 1995 Jun 2;81(5):695–704. doi: 10.1016/0092-8674(95)90531-6. [DOI] [PubMed] [Google Scholar]
  35. Soria J. M., Morell M., Jiménez-Astorga C., Estivill X., Sala N. Severe type I protein C deficiency in a compound heterozygote for Y124C and Q132X mutations in exon 6 of the PROC gene. Thromb Haemost. 1995 Nov;74(5):1215–1220. [PubMed] [Google Scholar]
  36. Stenflo J., Fernlund P. Amino acid sequence of the heavy chain of bovine protein C. J Biol Chem. 1982 Oct 25;257(20):12180–12190. [PubMed] [Google Scholar]
  37. Suh T. T., Holmbäck K., Jensen N. J., Daugherty C. C., Small K., Simon D. I., Potter S., Degen J. L. Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice. Genes Dev. 1995 Aug 15;9(16):2020–2033. doi: 10.1101/gad.9.16.2020. [DOI] [PubMed] [Google Scholar]
  38. Sun W. Y., Witte D. P., Degen J. L., Colbert M. C., Burkart M. C., Holmbäck K., Xiao Q., Bugge T. H., Degen S. J. Prothrombin deficiency results in embryonic and neonatal lethality in mice. Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7597–7602. doi: 10.1073/pnas.95.13.7597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Tanabe S., Sugo T., Matsuda M. Synthesis of protein C in human umbilical vein endothelial cells. J Biochem. 1991 Jun;109(6):924–928. doi: 10.1093/oxfordjournals.jbchem.a123481. [DOI] [PubMed] [Google Scholar]
  40. Taylor F. B., Jr, Lockhart M. S. Whole blood clot lysis: in vitro modulation by activated protein C. Thromb Res. 1985 Mar 15;37(6):639–649. doi: 10.1016/0049-3848(85)90193-8. [DOI] [PubMed] [Google Scholar]
  41. Tuddenham E. G., Takase T., Thomas A. E., Awidi A. S., Madanat F. F., Abu Hajir M. M., Kernoff P. B., Hoffbrand A. V. Homozygous protein C deficiency with delayed onset of symptoms at 7 to 10 months. Thromb Res. 1989 Mar 1;53(5):475–484. doi: 10.1016/0049-3848(89)90202-8. [DOI] [PubMed] [Google Scholar]
  42. Vehar G. A., Davie E. W. Preparation and properties of bovine factor VIII (antihemophilic factor). Biochemistry. 1980 Feb 5;19(3):401–410. doi: 10.1021/bi00544a001. [DOI] [PubMed] [Google Scholar]
  43. Weiler-Guettler H., Christie P. D., Beeler D. L., Healy A. M., Hancock W. W., Rayburn H., Edelberg J. M., Rosenberg R. D. A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state. J Clin Invest. 1998 May 1;101(9):1983–1991. doi: 10.1172/JCI2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Wood S. A., Allen N. D., Rossant J., Auerbach A., Nagy A. Non-injection methods for the production of embryonic stem cell-embryo chimaeras. Nature. 1993 Sep 2;365(6441):87–89. doi: 10.1038/365087a0. [DOI] [PubMed] [Google Scholar]
  45. Xue J., Wu Q., Westfield L. A., Tuley E. A., Lu D., Zhang Q., Shim K., Zheng X., Sadler J. E. Incomplete embryonic lethality and fatal neonatal hemorrhage caused by prothrombin deficiency in mice. Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7603–7607. doi: 10.1073/pnas.95.13.7603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Yoshitake S., Schach B. G., Foster D. C., Davie E. W., Kurachi K. Nucleotide sequence of the gene for human factor IX (antihemophilic factor B). Biochemistry. 1985 Jul 2;24(14):3736–3750. doi: 10.1021/bi00335a049. [DOI] [PubMed] [Google Scholar]
  47. Zhang L., Castellino F. J. A gamma-carboxyglutamic acid (gamma) variant (gamma 6D, gamma 7D) of human activated protein C displays greatly reduced activity as an anticoagulant. Biochemistry. 1990 Dec 4;29(48):10828–10834. doi: 10.1021/bi00500a016. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES